103 related articles for article (PubMed ID: 154982)
1. Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.
Taylor GM; Fergusson WD; Harris R
Clin Exp Immunol; 1979 Jan; 35(1):53-61. PubMed ID: 154982
[TBL] [Abstract][Full Text] [Related]
2. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
3. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
Zhong RK; Lane TA; Ball ED
Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
[TBL] [Abstract][Full Text] [Related]
4. Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia.
Klammer M; Waterfall M; Samuel K; Turner ML; Roddie PH
Br J Haematol; 2005 May; 129(3):340-9. PubMed ID: 15842657
[TBL] [Abstract][Full Text] [Related]
5. CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.
Zhong RK; Loken M; Lane TA; Ball ED
Cytotherapy; 2006; 8(1):3-12. PubMed ID: 16627340
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte transformation induced by autologous cells. X. Soluble factors that generate cytotoxic T lymphocytes.
Weksler ME; Moody CE; Ostry RF; Casazza BA
J Exp Med; 1980 Aug; 152(2 Pt 2):284s-291s. PubMed ID: 6447745
[TBL] [Abstract][Full Text] [Related]
7. Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.
Birnbaum G; Kotilinek L; Schwartz M; Sternad M
J Clin Invest; 1984 Oct; 74(4):1307-17. PubMed ID: 6237121
[TBL] [Abstract][Full Text] [Related]
8. Autologous peptides eluted from acute myeloid leukemia cells can be used to generate specific antileukemic CD4 helper and CD8 cytotoxic T lymphocyte responses in vitro.
Delluc S; Tourneur L; Michallet AS; Boix C; Varet B; Fradelizi D; Guillet JG; Buzyn A
Haematologica; 2005 Aug; 90(8):1050-62. PubMed ID: 16079104
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells fused with core binding factor-beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes.
Banat GA; Usluoglu N; Hoeck M; Ihlow K; Hoppmann S; Pralle H
Br J Haematol; 2004 Aug; 126(4):593-601. PubMed ID: 15287954
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human cytotoxic lymphocyte responses. II. Suppression by a soluble factor produced by primed lymphocytes.
Crosier PS; Broom BC
Immunology; 1981 May; 43(1):19-24. PubMed ID: 6454647
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity of lymphocyte subpopulations against autologous tumour cells in patients with myeloid leukaemias and preleukaemic disorders.
Szabó B; Váczi L; Tóth FD; Kiss J; Kiss A; Rák K
Acta Microbiol Hung; 1988; 35(1):25-33. PubMed ID: 3260709
[TBL] [Abstract][Full Text] [Related]
13. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
Draube A; Beyer M; Wolf J
Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T cells generated in the autologous mixed lymphocyte reaction. I. Primary autologous mixed lymphocyte reaction.
Tomonari K
J Immunol; 1980 Mar; 124(3):1111-21. PubMed ID: 6444646
[TBL] [Abstract][Full Text] [Related]
15. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
16. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
18. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
[TBL] [Abstract][Full Text] [Related]
19. Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
Cocks P; Powles RL; Chapuis B; Alexander P
Br J Cancer; 1977 Mar; 35(3):273-9. PubMed ID: 139910
[TBL] [Abstract][Full Text] [Related]
20. The suppression of mitogen- and alloantigen-stimulated peripheral blood lymphocytes by cultured human T lymphocytes.
Maca RD; Bonnard GD; Herberman RB
J Immunol; 1979 Jul; 123(1):246-51. PubMed ID: 156232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
